{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:55:21Z","timestamp":1768726521158,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genom Data"],"DOI":"10.1186\/s12863-025-01324-3","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T06:29:12Z","timestamp":1752301752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic profile of ASXL1 gene in risk assessment in acute myeloid leukemia"],"prefix":"10.1186","volume":"26","author":[{"given":"Salem Ahmed","family":"Bamusa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wardah","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atia","family":"Gohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishtiaq Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shakeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"13","key":"1324_CR1","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00018-019-03084-7","volume":"76","author":"S Asada","year":"2019","unstructured":"Asada S, Fujino T, Goyama S, Kitamura T. The role of ASXL1 in hematopoiesis and myeloid malignancies. Cell Mol Life Sci. 2019;76(13):2511\u201323.","journal-title":"Cell Mol Life Sci"},{"key":"1324_CR2","doi-asserted-by":"publisher","first-page":"e2300229","DOI":"10.1200\/GO.23.00229","volume":"9","author":"CT Jani","year":"2023","unstructured":"Jani CT, Ahmed A, Singh H, Mouchati C, Al Omari O, Bhatt PS, et al. Burden of AML, 1990\u20132019: estimates from the global burden of disease study. JCO Global Oncol. 2023;9:e2300229.","journal-title":"JCO Global Oncol"},{"issue":"3","key":"1324_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3324\/haematol.2011.051532","volume":"97","author":"M Pratcorona","year":"2012","unstructured":"Pratcorona M, Abbas S, Sanders MA, Koenders JE, Kavelaars FG, Erpelinck-Verschueren CA, et al. Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value. Haematologica. 2012;97(3):388.","journal-title":"Haematologica"},{"issue":"9","key":"1324_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","volume":"125","author":"RC Lindsley","year":"2015","unstructured":"Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125(9):1367\u201376.","journal-title":"Blood"},{"issue":"2","key":"1324_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/MOH.0b013e3283257a87","volume":"16","author":"LM Arfons","year":"2009","unstructured":"Arfons LM, Tomblyn M, Rocha V, Lazarus HM. Second hematopoietic stem cell transplantation in myeloid malignancies. Curr Opin Hematol. 2009;16(2):112\u201323.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"1324_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1182\/asheducation-2016.1.348","volume":"2016","author":"CD DiNardo","year":"2016","unstructured":"DiNardo CD, Cortes JE. Mutations in AML: prognostic and therapeutic implications. Hematol Am Soc Hematol Educ Program. 2016;2016(1):348\u201355.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"1324_CR7","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"key":"1324_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.exphem.2020.01.002","volume":"83","author":"T Fujino","year":"2020","unstructured":"Fujino T, Kitamura T. ASXL1 mutation in clonal hematopoiesis. Exp Hematol. 2020;83:74\u201384.","journal-title":"Exp Hematol"},{"key":"1324_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.exphem.2022.09.003","volume":"115","author":"X Gao","year":"2022","unstructured":"Gao X, You X, Droin N, Banaszak LG, Churpek J, Padron E, et al. Role of ASXL1 in hematopoiesis and myeloid diseases. Exp Hematol. 2022;115:14\u20139.","journal-title":"Exp Hematol"},{"issue":"1","key":"1324_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12935-021-02233-y","volume":"21","author":"Y Fan","year":"2021","unstructured":"Fan Y, Liao L, Liu Y, Wu Z, Wang C, Jiang Z, et al. Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia. Cancer Cell Int. 2021;21(1):526.","journal-title":"Cancer Cell Int"},{"key":"1324_CR11","doi-asserted-by":"publisher","first-page":"6962379","DOI":"10.1155\/2017\/6962379","volume":"2017","author":"M Wang","year":"2017","unstructured":"Wang M, Yang C, Zhang L, Schaar DG. Molecular mutations and their cooccurrences in cytogenetically normal acute myeloid leukemia. Stem Cells Int. 2017;2017:6962379.","journal-title":"Stem Cells Int"},{"issue":"5","key":"1324_CR12","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1111\/ajco.13897","volume":"19","author":"A Zhang","year":"2023","unstructured":"Zhang A, Wang S, Ren Q, Wang Y, Jiang Z. Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis. Asia-Pac J Clin Oncol. 2023;19(5):e183\u201394.","journal-title":"Asia-Pac J Clin Oncol"},{"key":"1324_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-8722-5-12","volume":"5","author":"V Gelsi-Boyer","year":"2012","unstructured":"Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ, Birnbaum D. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol. 2012;5:12.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1324_CR14","doi-asserted-by":"publisher","first-page":"e0204218","DOI":"10.1371\/journal.pone.0204218","volume":"13","author":"S Montes-Moreno","year":"2018","unstructured":"Montes-Moreno S, Routbort MJ, Lohman EJ, Barkoh BA, Kanagal-Shamanna R, Bueso-Ramos CE, et al. Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era. PLoS ONE. 2018;13(9):e0204218.","journal-title":"PLoS ONE"},{"issue":"1","key":"1324_CR15","first-page":"446","volume":"25","author":"Y Lin","year":"2020","unstructured":"Lin Y, Wang Y, Zheng Y, Wang Z, Wang Y, Wang S. Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with ASXL1 mutations. Hematol (Amsterdam Netherlands). 2020;25(1):446\u201356.","journal-title":"Hematol (Amsterdam Netherlands)"},{"issue":"13","key":"1324_CR16","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1111\/jcmm.17424","volume":"26","author":"M Parsa-Kondelaji","year":"2022","unstructured":"Parsa-Kondelaji M, Ayatollahi H, Rostami M, Sheikhi M, Barzegar F, Afzalaghaee M, et al. Evaluating the frequency, prognosis and survival of RUNX1 and ASXL1 mutations in patients with acute myeloid leukaemia in Northeastern Iran. J Cell Mol Med. 2022;26(13):3797\u2013801.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1324_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/leu.2012.262","volume":"27","author":"S Schnittger","year":"2013","unstructured":"Schnittger S, Eder C, Jeromin S, Alpermann T, Fasan A, Grossmann V, et al. ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia. 2013;27(1):82\u201391.","journal-title":"Leukemia"},{"key":"1324_CR18","doi-asserted-by":"publisher","unstructured":"Panuzzo C, Signorino E, Calabrese C, Ali MS, Petiti J, Bracco E et al. Landscape of tumor suppressor mutations in acute myeloid leukemia. J Clin Med. 2020;9(3):802. https:\/\/doi.org\/10.3390\/jcm9030802.","DOI":"10.3390\/jcm9030802"},{"key":"1324_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2147\/CIA.S375000","volume":"17","author":"F Li","year":"2022","unstructured":"Li F, Li N, Wang A, Liu X. Correlation analysis and prognostic impacts of biological characteristics in elderly patients with acute myeloid leukemia. Clin Interv Aging. 2022;17:1187\u201397.","journal-title":"Clin Interv Aging"},{"issue":"4","key":"1324_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cncr.32566","volume":"126","author":"K Sasaki","year":"2020","unstructured":"Sasaki K, Kanagal-Shamanna R, Montalban-Bravo G, Assi R, Jabbour E, Ravandi F, et al. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia. Cancer. 2020;126(4):765\u201374.","journal-title":"Cancer"},{"key":"1324_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2020.00560","volume":"11","author":"S Shahid","year":"2020","unstructured":"Shahid S, Shakeel M, Siddiqui S, Ahmed S, Sohail M, Khan IA, et al. Novel genetic variations in acute myeloid leukemia in Pakistani population. Front Genet. 2020;11:1\u201310.","journal-title":"Front Genet"},{"issue":"20","key":"1324_CR22","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"key":"1324_CR23","unstructured":"Simon Andrews. FastQC: A quality control tool for high throughput sequence data 2010. Available from: https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"issue":"15","key":"1324_CR24","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"5","key":"1324_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics. 2010;26(5):589\u201395.","journal-title":"Bioinformatics"},{"issue":"16","key":"1324_CR26","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and samtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"9","key":"1324_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"Supplement 1","key":"1324_CR28","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1182\/blood-2022-170618","volume":"140","author":"K Obeidat","year":"2022","unstructured":"Obeidat K, Turk E, Deenadayalan V, Litvin R, Zia M, Rifkin SD. Demographic characteristics and outcomes in patients with AML and previous diagnosis of CML or MDS. Blood. 2022;140(Supplement 1):8942\u20133.","journal-title":"Blood"},{"key":"1324_CR29","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1182\/blood-2024-211874","volume":"144","author":"Z Li","year":"2024","unstructured":"Li Z, Yu L, Hu L-J, Zhao T, Duan W, Wang J, et al. Sex differences in disease characteristics and outcome in adults with acute myeloid leukemia from China. Blood. 2024;144:6121.","journal-title":"Blood"},{"issue":"10","key":"1324_CR30","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1080\/10428194.2022.2081323","volume":"63","author":"J Xu","year":"2022","unstructured":"Xu J, Hao Z, Chen X, Hong M, Muyey DM, Chen X, et al. The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next generation sequencing. Leuk Lymphoma. 2022;63(10):2321\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"1324_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10(6):845\u201358.","journal-title":"Nat Protoc"}],"container-title":["BMC Genomic Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-025-01324-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12863-025-01324-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-025-01324-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:13:06Z","timestamp":1757225586000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenet.biomedcentral.com\/articles\/10.1186\/s12863-025-01324-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1186\/s12863-025-01324-3","relation":{},"ISSN":["2730-6844"],"issn-type":[{"value":"2730-6844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Independent Ethics Committee, International Center for Chemical and Biological Sciences, University of Karachi. An informed written consent to participate in this study was obtained from the patients or their legal guardian\/next of kin, in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent was obtained from the study participants for the publication of the results anonymously.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}